Skip to main content

Table 4 Mean attacks per day

From: Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review

Author

No. of patients

Mean at baseline (SD)

Mean at the end (SD)

Mean change vs. baseline

Mean % change vs. baseline

Wu et al. [56] placebo

week 1

20

20.5(10.4)

18.5

2

10

week 4

20

20.5(10.4)

18.8

1.7

8

week 8

20

20.5(10.4)

17.7

2.8

14

week 12

20

20.5(10.4)

18.2

2.3

11

Wu et al. [56] BTX-A

week 1

22

21.7(22.7)

8.4

13.3

61a

week 4

22

21.7(22.7)

4.7

17

78a

week 8

22

21.7(22.7)

2.3

19.4

89a

week 12

22

21.7(22.7)

1.8

19.9

92a

Bohluli et al. [57]

week 1

15

33.0(18.9)

3.6(5.4)

29.4

89b

month 1

15

33.0(18.9)

4.1(5.8)

28.9

88b

Türk et al. [59]

week 1

8

Unclear

Unclear

Unclear

Unclearb

month 2

8

Unclear

Unclear

Unclear

Unclearb

month 6

8

Unclear

Unclear

Unclear

Unclearb

  1. a p < 0.05 vs placebo.
  2. b p < 0.05 vs baseline.